
Oviva Therapeutics: Advancing women's health through innovative biotech solutions in ovarian physiology.
Oviva Therapeutics, founded with a core mission to advance women's health, focuses on research and development in ovarian physiology. The company's vision is to improve the healthspan of women by developing first-in-class therapeutics aimed at protecting the ovarian reserve and extending ovarian function. Currently in advanced preclinical stages, Oviva Therapeutics targets age-related decline in ovarian function, which leads to various adverse health outcomes in women.
Notable affiliated individuals and investors include experts in biotechnology and women's health, although specific names are not provided. Key achievements involve progressing to advanced preclinical stages with their novel therapeutic solutions. Oviva Therapeutics has made a significant impact by elevating the conversation around women's health and building a coalition dedicated to this cause, aiming to transform the landscape of female healthspan through innovative biotech solutions.

Ovid Therapeutics
ovidrx.com

ProFound Therapeutics
profoundtx.com

Oova
oova.life

Nested Therapeutics
nestedtx.com

Aspira Women's Health
aspirawh.com

Rejuveron Life Sciences
rejuveron.com

Nora Therapeutics

Aurion Biotech
aurionbiotech.com

Estrigenix Therapeutics
estrigenix.com

BioViva

Akttyva Therapeutics
akttyva.com

Celmatix
celmatix.com

Juvenescence
juvlabs.com

Visiox
visioxpharma.com

Granata Bio
granata.bio
Companies similar to Oviva Therapeutics include Ovid Therapeutics, ProFound Therapeutics, Oova and Nested Therapeutics.
Oviva Therapeutics was founded in 2021.
Oviva Therapeutics' headquarters is located in New York City, NY, US.
Oviva Therapeutics' most recent funding round was for $11.5M (USD) in May 2022.
As of May 19, 2022, Oviva Therapeutics has raised a total of $11.5M (USD).
Oviva Therapeutics has 30 employees as of Feb 5, 2024.